Terms: = Germ cell tumor AND SDHB, PGL4, 6390, ENSG00000117118, SDH1, SDHIP, SDH, IP
1251 results:
1. Astragaloside IV combined with ligustrazine ameliorates abnormal mitochondrial dynamics via Drp1 SUMO/deSUMOylation in cerebral ischemia-reperfusion injury.
Chen X; Yang T; Zhou Y; Mei Z; Zhang W
CNS Neurosci Ther; 2024 Apr; 30(4):e14725. PubMed ID: 38615367
[TBL] [Abstract] [Full Text] [Related]
2. OMA1 competitively binds to HSPA9 to promote mitophagy and activate the cGAS-STING pathway to mediate GBM immune escape.
Zhu W; Rao J; Zhang LH; Xue KM; Li L; Li JJ; Chen QZ; Fu R
J Immunother Cancer; 2024 Apr; 12(4):. PubMed ID: 38604814
[TBL] [Abstract] [Full Text] [Related]
3. [Clinical features of patients with metastatic pheochromocytoma/paraganglioma].
Cui YY; Zhou Y; Gao YJ; Li TY; Wang Y; Zhang WQ; Zhou T; Chen S; Tong AL
Zhonghua Yi Xue Za Zhi; 2024 Apr; 104(14):1174-1179. PubMed ID: 38583049
[No Abstract] [Full Text] [Related]
4. PSMA2 promotes glioma proliferation and migration via EMT.
Zhang Y; Xiang Z; Chen L; Deng X; Liu H; Peng X
Pathol Res Pract; 2024 Apr; 256():155278. PubMed ID: 38574629
[TBL] [Abstract] [Full Text] [Related]
5. SIRT5 promote malignant advancement of chordoma by regulating the desuccinylation of c-myc.
Jiang M; Huang Z; Chen L; Deng T; Liu J; Wu Y
BMC Cancer; 2024 Mar; 24(1):386. PubMed ID: 38532359
[TBL] [Abstract] [Full Text] [Related]
6. Early B cell Factor 3 (EBF3) attenuates Parkinson's disease through directly regulating contactin-associated protein-like 4 (CNTNAP4) transcription: An experimental study.
Hu W; Wang M; Sun G; Zhang L; Lu H
Cell Signal; 2024 Jun; 118():111139. PubMed ID: 38479556
[TBL] [Abstract] [Full Text] [Related]
7. The Prevalence and Radiologic Features of Renal Cancers Associated with
Charbel C; Causa Andrieu PI; Soliman M; Woo S; Zheng J; Capanu M; Nikolovski I; Vargas HA; Abusamra M; Carlo MI
Radiol Imaging Cancer; 2024 Mar; 6(2):e230063. PubMed ID: 38456787
[TBL] [Abstract] [Full Text] [Related]
8. Sex-related differences in serum biomarker levels predict the activity and efficacy of immune checkpoint inhibitors in advanced melanoma and non-small cell lung cancer patients.
Pasello G; Fabricio ASC; Del Bianco P; Salizzato V; Favaretto A; Piccin L; Zustovich F; Fabozzi A; De Rossi C; Pigozzo J; De Nuzzo M; Cappelletto E; Bonanno L; Palleschi D; De Salvo GL; Guarneri V; Gion M; Chiarion-Sileni V
J Transl Med; 2024 Mar; 22(1):242. PubMed ID: 38443899
[TBL] [Abstract] [Full Text] [Related]
9. Pediatric malignant pheochromocytoma with atypical presentation as vision changes, lung metastasis, and recurrence: a case report.
Zhang K; Yang P; Li M; Xiang P; Cheng Z; Zhou X
J Med Case Rep; 2024 Mar; 18(1):134. PubMed ID: 38439039
[TBL] [Abstract] [Full Text] [Related]
10. Sunitinib for metastatic progressive phaeochromocytomas and paragangliomas: results from FIRSTMAPPP, an academic, multicentre, international, randomised, placebo-controlled, double-blind, phase 2 trial.
Baudin E; Goichot B; Berruti A; Hadoux J; Moalla S; Laboureau S; Nölting S; de la Fouchardière C; Kienitz T; Deutschbein T; Zovato S; Amar L; Haissaguerre M; Timmers H; Niccoli P; Faggiano A; Angokai M; Lamartina L; Luca F; Cosentini D; Hahner S; Beuschlein F; Attard M; Texier M; Fassnacht M; ;
Lancet; 2024 Mar; 403(10431):1061-1070. PubMed ID: 38402886
[TBL] [Abstract] [Full Text] [Related]
11. TRIM25 promotes glioblastoma cell growth and invasion via regulation of the PRMT1/c-MYC pathway by targeting the splicing factor NONO.
Chen Y; Xu X; Ding K; Tang T; Cai F; Zhang H; Chen Z; Qi Y; Fu Z; Zhu G; Dou Z; Xu J; Chen G; Wu Q; Ji J; Zhang J
J Exp Clin Cancer Res; 2024 Feb; 43(1):39. PubMed ID: 38303029
[TBL] [Abstract] [Full Text] [Related]
12. Outcomes of systemic treatment according to germline mutational status in patients with metastatic pheochromocytoma and paraganglioma.
Park YG; Park I; Kim Y; Lee HS; Lee W; Yoon S; Lee JL
Clin Genitourin Cancer; 2024 Apr; 22(2):413-419. PubMed ID: 38228412
[TBL] [Abstract] [Full Text] [Related]
13. Novel alternative tools for metastatic pheochromocytomas/paragangliomas prediction.
Cui Y; Zhou Y; Gao Y; Ma X; Wang Y; Zhang X; Zhou T; Chen S; Lu L; Zhang Y; Chang X; Tong A; Li Y
J Endocrinol Invest; 2024 May; 47(5):1191-1203. PubMed ID: 38206552
[TBL] [Abstract] [Full Text] [Related]
14. Malignant carotid body tumors: What we know, what we do, and what we need to achieve. A systematic review of the literature.
Piazza C; Lancini D; Tomasoni M; Zafereo M; Poorten VV; Hanna E; Mäkitie AA; Fernandez-Alvarez V; Kowalski LP; Chiesa-Estomba C; Ferlito A
Head Neck; 2024 Mar; 46(3):672-687. PubMed ID: 38179805
[TBL] [Abstract] [Full Text] [Related]
15. Development and internal validation of a novel predictive model for
Zhou Y; Gao Y; Ma X; Li T; Cui Y; Wang Y; Li M; Zhang D; Tong A
Front Endocrinol (Lausanne); 2023; 14():1285631. PubMed ID: 38179299
[TBL] [Abstract] [Full Text] [Related]
16. Pan-cancer ion transport signature reveals functional regulators of glioblastoma aggression.
Bahcheli AT; Min HK; Bayati M; Zhao H; Fortuna A; Dong W; Dzneladze I; Chan J; Chen X; Guevara-Hoyer K; Dirks PB; Huang X; Reimand J
EMBO J; 2024 Jan; 43(2):196-224. PubMed ID: 38177502
[TBL] [Abstract] [Full Text] [Related]
17. Local recurrence and metastatic disease in pheochromocytomas and sympathetic paragangliomas.
Araujo-Castro M; García Sanz I; Mínguez Ojeda C; Hanzu F; Mora M; Vicente A; Blanco Carrera C; de Miguel Novoa P; López García MDC; Lamas C; Manjón-Miguélez L; Del Castillo Tous M; Rodríguez de Vera P; Barahona San Millán R; Recasens M; Tomé Fernández-Ladreda M; Valdés N; Gracia Gimeno P; Robles Lazaro C; Michalopoulou T; Álvarez Escolá C; García Centeno R; Barca-Tierno V; Herrera-Martínez AD; Calatayud M
Front Endocrinol (Lausanne); 2023; 14():1279828. PubMed ID: 38155946
[TBL] [Abstract] [Full Text] [Related]
18. An aggressive cabergoline-resistant, temozolomide-responsive macroprolactinoma due to a germline
Alzahrani AS; Bin Nafisah A; Alswailem M; Moria Y; Poprawski D; Al-Hindi H; Pacak K
Front Endocrinol (Lausanne); 2023; 14():1273093. PubMed ID: 38152133
[TBL] [Abstract] [Full Text] [Related]
19. A comprehensive characterisation of phaeochromocytoma and paraganglioma tumours through histone protein profiling, DNA methylation and transcriptomic analysis genome wide.
Chatzikyriakou P; Brempou D; Quinn M; Fishbein L; Noberini R; Anastopoulos IN; Tufton N; Lim ES; Obholzer R; Hubbard JG; Moonim M; Bonaldi T; Nathanson KL; Izatt L; Oakey RJ
Clin Epigenetics; 2023 Dec; 15(1):196. PubMed ID: 38124114
[TBL] [Abstract] [Full Text] [Related]
20. Neuronal-specific TNFAIP1 ablation attenuates postoperative cognitive dysfunction via targeting SNAP25 for K48-linked ubiquitination.
Wang W; Gao W; Gong P; Song W; Bu X; Hou J; Zhang L; Zhao B
Cell Commun Signal; 2023 Dec; 21(1):356. PubMed ID: 38102610
[TBL] [Abstract] [Full Text] [Related]
[Next]
